Literature DB >> 23880208

Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.

A E Berezin1, A A Kremzer.   

Abstract

OBJECTIVE: To evaluate the interrelation between circulating osteopontin (OPN) and coronary atherosclerosis and calcification in type 2 diabetes mellitus patients (T2DM). DESIGN AND METHODS: 126 subjects (46 patients with T2DM) with previously documented asymptomatic coronary artery disease (CAD) were enrolled in the study. CAD was determined by contrast multispiral CT-angiography. OPN plasma levels were measured by ELISA.
RESULTS: Analysis of the results showed that in a patient cohort the mean value of circulating OPN was 43.55 ng/mL (95% CI = 31.5-57.0 ng/mL). OPN plasma levels were correlated with Agatston score index (r = 0.418, P = 0.009), T2DM (r = 0.411, P = 0.006), gender (r = 0.395, P < 0.001 for male), TC (r = 0.405, P = 0.006), hsC-RP (r = 0.368, P = 0.008), age (r = 0.256, P = 0.001), smoking (r = 0.255, P = 0.001) and inversely to LVEF (r = -0.579, P = 0.001). Cox-regression analyzes showed that in T2DM patients upper quartile OPN compared with the lowest quartile are associated with Agatston score index (adjusted OR = 3.23, 95% CI = 1.09-5.20; P = 0.044), numerous of damaged coronary arteries (adjusted OR = 2.60, 95% CI = 1.10-9.20, P = 0.005). The findings suggest that the predictive power of the model for asymptomatic CAD patients with T2DM, the estimated AUC (area under curve) was 0.788. In this case, the concentration of OPN that had the best predict potential on the risk of coronary atherosclerosis was 48.5 ng/mL. In conclusions, we believe that elevated OPN in plasma can be considered as an independent predictor of coronary calcification in T2DM patients with known CAD.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Artery calcification; Asymptomatic atherosclerosis; Osteopontin; Predicted value; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2013        PMID: 23880208     DOI: 10.1016/j.atherosclerosis.2013.06.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

1.  Relationship of osteopontin and renal function with severity of coronary artery lesions.

Authors:  Jian Chen; Yingmin Lu; Damin Huang; Xiaohan Luo; Yachen Zhang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Pregnancy history, coronary artery calcification and bone mineral density in menopausal women.

Authors:  J P Beckman; J J Camp; B D Lahr; K R Bailey; A E Kearns; V D Garovic; M Jayachandran; V M Miller; D R Holmes
Journal:  Climacteric       Date:  2017-11-30       Impact factor: 3.005

3.  AGEs induce ectopic endochondral ossification in intervertebral discs

Authors:  S Illien-Jünger; O M Torre; W F Kindschuh; X Chen; D M Laudier; J C Iatridis
Journal:  Eur Cell Mater       Date:  2016-11-18       Impact factor: 3.942

4.  Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.

Authors:  Abdullah A Aldossari; Jonathan H Shannahan; Ramakrishna Podila; Jared M Brown
Journal:  Toxicol In Vitro       Date:  2015-02       Impact factor: 3.500

5.  High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes.

Authors:  T Filardi; V Carnevale; R Massoud; C Russo; L Nieddu; F Tavaglione; I Turinese; A Lenzi; E Romagnoli; S Morano
Journal:  J Endocrinol Invest       Date:  2018-06-18       Impact factor: 4.256

6.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

7.  ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.

Authors:  Barnabas Gellen; Nathalie Thorin-Trescases; Philippe Sosner; Elise Gand; Pierre-Jean Saulnier; Stéphanie Ragot; Mathilde Fraty; Stéphanie Laugier; Grégory Ducrocq; David Montaigne; Pierre Llaty; Vincent Rigalleau; Philippe Zaoui; Jean-Michel Halimi; Ronan Roussel; Eric Thorin; Samy Hadjadj
Journal:  Diabetologia       Date:  2016-08-04       Impact factor: 10.122

8.  The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.

Authors:  Z A Yegin; Ö T İyidir; C Demirtaş; E Suyanı; İ Yetkin; H Paşaoğlu; Ç İlhan; G T Sucak
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

9.  Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort.

Authors:  Barnabas Gellen; Nathalie Thorin-Trescases; Eric Thorin; Elise Gand; Philippe Sosner; Sonia Brishoual; Vincent Rigalleau; David Montaigne; Vincent Javaugue; Yann Pucheu; Philippe Gatault; Xavier Piguel; Samy Hadjadj; Pierre-Jean Saulnier
Journal:  Diabetologia       Date:  2020-02-10       Impact factor: 10.122

10.  Bone mineral density is associated with left ventricular diastolic function in women.

Authors:  Rui-Tao Wang; Xue-Song Li; Ji-Rong Zhang; Yuxiang Sun; Kai-Jiang Yu; Tiemin Liu
Journal:  Clin Cardiol       Date:  2016-10-07       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.